All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
Strongbridge Biopharma plc, of Trevose, Pa., said the underwriters of its public offering of 5 million ordinary shares have partially exercised their option to purchase an additional 255,683 ordinary shares from the company at $6.75 per share.